Caifeng Xie
- Toxicology top 5%
- Cancer Research top 10%
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 4
- Pharmacological Effects of Natural Compounds 3
-
- Peroxisome Proliferator-Activated Receptors 6
- Natural product bioactivities and synthesis 5
- Metabolism, Diabetes, and Cancer 4
-
- Cytokine Signaling Pathways and Interactions 5
-
- Liver Disease Diagnosis and Treatment 4
- Adipokines, Inflammation, and Metabolic Diseases 3
- Cited by
- ToxicologyCancer ResearchImmunology
- Journals
- Journal of Biological Chemistry (1 paper)PLoS ONE (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Caifeng Xie
39 papers receiving 970 citations
Peers
Comparison fields: 5 of 95
- Toxicology 50
- Cancer Research 205
- Immunology 185
- Pharmacology 73
- Molecular Biology 521
Countries citing papers authored by Caifeng Xie
This map shows the geographic impact of Caifeng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caifeng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caifeng Xie more than expected).
Fields of papers citing papers by Caifeng Xie
This network shows the impact of papers produced by Caifeng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caifeng Xie. The network helps show where Caifeng Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caifeng Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 0 | |
| 5 | 2020 | 39 | |
| 6 | 2019 | 3 | |
| 7 | 2018 | 2 | |
| 8 | 2017 | 31 | |
| 9 | 2016 | 51 | |
| 10 | 2015 | 5 | |
| 11 | 2014 | 9 | |
| 12 | 2014 | 27 | |
| 13 | 2014 | 31 | |
| 14 | 2013 | 89 | |
| 15 | 2013 | 11 | |
| 16 | 2013 | 26 | |
| 17 | 2012 | 5 | |
| 18 | 2011 | 7 | |
| 19 | 2011 | 7 | |
| 20 | 2011 | 35 |
About Caifeng Xie
Caifeng Xie is a scholar working on Pharmacology, Toxicology and Cancer Research, having authored 42 papers that have together received 980 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (6 papers), Natural product bioactivities and synthesis (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Toxicology (50 citations), Cancer Research (205 citations) and Immunology (185 citations). Caifeng Xie has collaborated with scholars based in China, United States and India. Frequent co-authors include Mingxi Gan, Tianyu Han, Jianbin Wang, Song Zhang, Lijuan Chen, Weihua Zhan, Liang Ma, Haoyu Ye, Heying Pei and Shucai Li. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.